Cargando…

Oncogenes and the molecular biology of cancer

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1983
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2112711/ https://www.ncbi.nlm.nih.gov/pubmed/6643573

Ejemplares similares

The Biology of Oncogenic Viruses
por: Miller, J. George
Publicado: (1973)

The Biology of the Ets1 Proto-Oncogene
por: Dittmer, Jürgen
Publicado: (2003)

Advances in Molecular Research of Oncogenes
por: Baltanas, Fernando C., et al.
Publicado: (2023)

A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas
por: Mani, Kartik M, et al.
Publicado: (2008)

Molecular Alterations of KIT Oncogene in Gliomas
por: Gomes, Ana L., et al.
Publicado: (2007)

Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis
por: Sivakumar, Shivan, et al.
Publicado: (2017)

Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer
por: Wang, Hantao, et al.
Publicado: (2021)

A pan-cancer analysis of molecular characteristics and oncogenic role of gasdermins
por: Mu, Mingchao, et al.
Publicado: (2022)

KRAS oncogene in lung cancer: focus on molecularly driven clinical trials
por: Kempf, Emmanuelle, et al.
Publicado: (2016)

Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges
por: Dasgupta, Subhamoy, et al.
Publicado: (2012)

Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3
por: Liu, Zihao, et al.
Publicado: (2022)

Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells
por: Brown, Geoffrey
Publicado: (2021)

Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
por: Calabrese, Fiorella, et al.
Publicado: (2022)

Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies
por: Ocana, Alberto, et al.
Publicado: (2017)

The molecular biology of cancer /
Publicado: (2006)

The Molecular Biology of Cancer
por: Emuss, V
Publicado: (2006)

Oncogenic human papillomavirus in breast cancer: molecular prevalence in a group of Congolese patients
por: Boumba, Anicet Luc Magloire, et al.
Publicado: (2021)

Establishment of a Novel In Vitro Model of Endometriosis with Oncogenic KRAS and PIK3CA Mutations for Understanding the Underlying Biology and Molecular Pathogenesis
por: Hossain, Mohammad Mahmud, et al.
Publicado: (2021)

Oncogene addiction in gliomas: Implications for molecular targeted therapy
por: Yan, Wei, et al.
Publicado: (2011)

Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms
por: Jia, Qunying, et al.
Publicado: (2020)

Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021)

Cancer, oncogenes and signal transduction
por: McManus, Edward J, et al.
Publicado: (2004)

Molecular carcinogenesis and the molecular biology of human cancer /
Publicado: (2006)

Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors
por: Tuna, Musaffe, et al.
Publicado: (2019)

Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides
por: Wang, Dali, et al.
Publicado: (2022)

A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
por: Van Sciver, Robert E., et al.
Publicado: (2018)

Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc
por: Roccato, E, et al.
Publicado: (2002)

Biological activity of the thyroid TRK-T3 oncogene requires signalling through Shc
por: Roccato, E, et al.
Publicado: (2016)

Molecular Detection of Fusion Oncogenes in Zambian Patients with Acute Lymphoblastic Leukemia
por: Okuku, Pauline, et al.
Publicado: (2020)

Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker
por: Zhang, Hui, et al.
Publicado: (2019)

Oncogene Overdose: Too Much of a Bad Thing for Oncogene-Addicted Cancer Cells
por: Amin, Amit Dipak, et al.
Publicado: (2015)

Targeted Cancer Therapy: Vital Oncogenes and a New Molecular Genetic Paradigm for Cancer Initiation Progression and Treatment
por: Willis, Rudolph E.
Publicado: (2016)

Oncogenic KRAS signalling in pancreatic cancer
por: Eser, S, et al.
Publicado: (2014)

The Relevance of Oncogene-Induced Apoptosis in Cancer
por: Evan, Gerard
Publicado: (2001)

Oncogene-Driven Metabolic Alterations in Cancer
por: Min, Hye-Young, et al.
Publicado: (2018)

Oncogenic driver mutations in lung cancer
por: Luo, Susan Y, et al.
Publicado: (2013)

When oncogenes do not cause cancer
por: Shiu, Jessica, et al.
Publicado: (2021)

Interrelated Oncogenic Viruses and Breast Cancer
por: Afzal, Samia, et al.
Publicado: (2022)

The oncogenic roles of JC polyomavirus in cancer
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

Oncogenic Role of ADAM32 in Hepatoblastoma: A Potential Molecular Target for Therapy
por: Fukazawa, Takahiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bguck4rv3rif4ep9v4hfd8id7t